Acorda MS Drug Patents Survive Kyle Bass PTAB Challenges
The Patent Trial and Appeal Board on Thursday upheld four of Acorda Therapeutics Inc.'s patents for its multiple sclerosis drug Ampyra, shooting down a challenge from the Coalition for Affordable Drugs,...To view the full article, register now.
Already a subscriber? Click here to view full article